Plain-language summary
Clinical-trial literature evaluating oral L-carnosine in women with polycystic ovary syndrome — a metabolic-endocrine condition tightly linked to insulin resistance and oxidative stress. Reported endpoints span insulin sensitivity, androgen profile, and circulating oxidative-stress markers, all of which move modestly in the expected direction with active supplementation.
Key takeaways
- ›Targets a population where oxidative stress and insulin resistance overlap.
- ›Endpoint pattern matches carnosine's broader metabolic story.
- ›Expands the human evidence base beyond classic diabetes cohorts.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.